Marie Curie Initial Training Network


  • February 2016
    Our associate partner Centre for Process Innovation (CPI) begins interviewing the partners to analyse the project results and identify the commercial readiness.
  • January 2016
    An ethical audit of the project is awarded favourable opinion by the EC.

    The 8th workshop in the series is hosted by Prof. Evi Weissinger in Hannover, entitled "Cellular Therapy and Monitoring of CMV after allogenic HSCT". This involved a mixture of practical and lecture sessions including talks on 'How to start a small/medium enterprise: From the Universities to Industry' and ATMPS and clinical trials.
  • December 2015
    Writing begins for a special edition journal to be published in Frontiers of Immunology entitled Cellular Therapies: Past, Present and Future, with a submission target date of April 2016.
  • October 2015
    Prof. Ralf Dressel (WP 2) successfully publishes article "The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation" in the open access journal EMBO Molecular Medicine. Prof. Ilona Hromadikova
    (WP 3) successfully publishes article "Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp-70-Derived 14-mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors" in Mediators of Inflammation.

    The second progress report is successfully submitted to the European Commission.
  • September 2015
    The 6th consortium meeting takes place via video conference.
  • August 2015
    Partner 10, Technical University Munich, recruits a new Experienced Researcher Maxim Shevtsov to continue the project within work package 4.
  • July 2015
    Prof. Ernst Holler (WP 3) successfully publishes article "Low urinary indoxylsulfate levels early after ASCT reflect a disrupted microbiome and are associated with poor outcome" in Blood.
  • June 2015
    Newcastle University hosts the 6th and 7th workshops in the Transferable Skills series for the project fellows.
  • 24-26th June
    Business Development, in collaboration with Centre for Process Innovation, NewGene, Alcyomics Ltd, NHS Innovations North and Enterprise Europe Network.
    See the final programme of the workshop here
  • 29-30th June
    Molecular Biology, in collaboration with NewGene, Affymetrix Ltd, Newcastle upon Tyne NHS Foundations Trust and Nanostring Technologies.
    See the final programme of the workshop here
  • 22 - 25 March 2015, Istanbul, Turkey
    Fantastic Abstract Outcomes! 41st meeting of the European Society for Blood and Marrow Transplantation Meeting, 2015.
    Congratulations to all of the fellows who submitted abstracts and a special congratulations to the following fellows who have been successful:
    Justyna Ogonek (Hannover Medical School) has been accepted for oral presentation.
    Rihab Gam (Newcastle University) submitted two abstracts, both of which have been accepted. One for oral/poster presentation and the other for a poster presentation.
    Monica Correia dos Reis (Newcastle University) has had her abstract accepted for poster display.
    Mateja Kralj (Medical University of Vienna) has been accepted for poster presentation.
    Marsela Qesari (Alcyomics Ltd) has been accepted for poster presentation.
    Shuang Li (Charles University, Prague) submitted two abstracts and will present two posters.
  • Wednesday 21st January 2015 at 12.30
    Institute Research Student Seminars
    Venue: Seminar room L2.5, 2nd floor, William Leech Building, Medical School
    Speakers: Rihab Gam & Thomas Hellyer

    Rihab Gam will present: “MICA genotype, serum and gene expression level effects on the outcome of HSCT”
    Graft-versus-host disease (GvHD) is a serious complication of allogeneic haematopoietic stem cell transplantation (allo-HSCT). The immunopathology of GvHD involves secretion of proinflammatory cytokines with subsequent expression of danger signals by the affected tissues. MHC class I chain–related gene A (MICA), is a stress induced molecule that acts as danger signal to alert NK and αβ or γõ CD8 T cells through engagement of the activating NKG2D receptor. We investigated MICA genotype together with serum and mRNA expression levels in the development and progression of GvHD.

    Key words: GvHD, biomarker, allo-HSCT

    Thomas Hellyer will discuss: “Rapid novel biomarker-based exclusion of ventilator-associated pneumonia”
    Ventilator-associated pneumonia (VAP) is a common nosocomial infection in the intensive care unit. Since VAP has an increased mortality and morbidity, patients with suspected VAP are treated with antibiotics at the point of suspicion. However only approximately 30% of this group of patients will go on to have infection confirmed suggesting that antibiotics are overused and there is scope to improve antibiotic stewardship. We have conducted a multi-centre validation study of a novel biomarker-based test that can exclude VAP with high certainty. Whether this new diagnostic tool can ultimately lead to a change in prescription practice and improve antibiotic stewardship is the focus of our ongoing randomised controlled trial.

    Key words: biomarker, pneumonia, randomised controlled trial Chair: Marco Silipo

    Flyer for the ICM student Seminar here

  • October 2014,
    Newcastle University hosted the 5th workshop in the series 20th – 22nd October on Immunohistochemistry, in collaboration of the Alcyomics Ltd and Haukeland University Hospital Bergen.
    See the final programme
    of the workshop here
  • September 2014,
    The project received favourable feedback from the Independent Expert and Scientific Officer, both of whom reviewed the project status at the Mid Term Review meeting in July. The Consortium will review the feedback and act accordingly in time for submission of the next report in November 2014.
  • August 2014,
    The Marie Sklodowska-Curie actions announces that it will hold its second Awards Ceremony of the Marie Sklodowska-Curie Prizes in 3 categories, open to all FP7 MSCA Fellows and alumni. A draft programme and pre-registration form are available at
  • July 2014,
    The Consortium welcomed the Project Officer and an Independent Expert to the Baltic Quays, Gateshead for the project Mid Term Review meeting, 17-18th July 2014. The project was reviewed by the representatives from the Research Executive Agency working for the European Commission. All the fellows presented a power point and a poster of their work to date.

  • Newcastle University, UK hosted a successful Transferable Skills week for the fellows, 21-25th July 2014. This interactive week was led by both external and in-house training facilitators and included the topics; Effective Communication, Conferences and Networking, Social Media, Scientific Writing, and Entrepreneurial Research.

  • Celleurope Co-ordinator Prof.Anne Dickinson hosted a workshop session, ‘Cellular Therapies’ at the Tissue and Cell Engineering Society Annual Meeting, Newcastle.2-4th July, 2014. Read more about the workshop here.http://conferences.ncl.ac.uk/tces2014 /conference/scientificprogrammeconferencebooklet/
  • June 2014,
    The University of Oslo hosted the 4th workshop in the series on 30th June 2014 - 1st July 2014 on Comparative Genomics and Animal Bone Marrow Transplantation.
    Read a summary of
    the workshop here.

  • April 2014,
    Celleurope Co-ordinator Prof.Anne Dickinson took part in an interactive workshop showcasing 'EU-funded projects on Cellular Therapies' during the International Society for Cellular Therapy (ISCT) 20th Anniversary meeting held in Paris, April 2014. Prof Dickinson presented the work of Celleurope and the objectives of the network. Also involved in the workshop were Dr. Pierre
    Layrolle, Co-ordinator of Reborne (http://www.reborne.org) , REDDSTAR Co-ordinator, Professor of Medicine Tim O'Brien NUI Galway (http://www.reddstar.eu), and Orbsen Therapeutics Head of Research, Dr. Steve Elliman (www.orbsentherapeutics.com).
  • Prof Ernst Holler gave plenary lectures in the educational session on GvHD and a lecture in the Immunobiology Working Party Session with the title: "Immunoregulatory loops in intestinal GvHD: Focus on microbiome and IDO" during the Annual EBMT meeting in Milan, Italy in April 2014. The presentation directly related to the rationale and results of Celleurope.
  • Celleurope is proud to announce that Early Stage Researcher Rihab Gam based at Newcastle University, has been awarded a Gold Sponsorhsip Award from Primerdesign Ltd. Selected on the merit of her project with Celleurope, Rihab will now receive over £3000 worth of qPCR kits along with training in real-time PCR and expert technical support from a Primerdesign representative. This is a fantastic opportunity for Rihab and will be a great support to the success of her project. Congratulations!
  • Marie Curie announce 4th ESOF Marie Sklodowska-Curie actions (MSCA) Conference in Copenhagen, Denmark this summer.